[Hyperkinetic syndromes. Therapeutic trials].
The Authors report their therapeutic experiences with RO 5/4023 begun in 1969, on some hyperkinetic syndromes. The casuistry includes six cases of facial spasm, three cases of Huntington disease, three cases of benign essential tremor, one case of Gilles de La Tourette disease. The favourable results of the drug are estimated in percentage that in somecases has reached 70%.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001570:Benzodiazepinones / Q000627:therapeutic use*; D002819:Chorea / Q000188:drug therapy; D002998:Clonazepam / Q000627:therapeutic use*; D004341:Drug Evaluation; D005158:Facial Paralysis / Q000188:drug therapy; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy*; D005879:Tourette Syndrome / Q000188:drug therapy; D014202:Tremor / Q000188:drug therapy
D001570:Benzodiazepinones; D002998:Clonazepam
Sindromi ipercinetiche. Tentativi terapeutici.